Showing posts with label Women. Show all posts
Showing posts with label Women. Show all posts

Tuesday, April 26, 2011

Divas with a Cause! June 19th!

4-time Dancing for Joan vocalist and band leader, Gwen Hughes, is a Diva with a Cause.  She'll be performing on Sunday, June 19th at The Buckhead Theater (formerly the Roxy) in Atlanta, Georgia.  

Gwen is representing The Joan Gaeta Lung Cancer Fund.  

Thanks, Gwen!

More information on the benefit concert coming soon!


The History of "Divas with a Cause"
by Maryline Blackburn

After finding out that my mother was at stage 3 of Renal Failure, Chronic Kidney Disease (CKD), I spent two months in Fairbanks, Alaska. I was nursing her back to some normalcy of health and the quality of life to which she was accustomed to living. I found that there was so much more for me to know about Kidney Disease, such as the symptoms, treatments, etc. I figured that if I did not know this, then surely there were other individuals who did not know either. I was appalled to find out that some 1.4 million Georgians suffer with Chronic Kidney Disease. I wanted to be able to share this, and began to think about how I could relay this information. What would truly grab the attention of the millions of individuals who, unbeknownst to them, have CKD knocking on their back door? I thought, well, people know me for singing, so what better way than through music!

As I began to visualize how I could get my message across, it occurred to me that there are other issues that people need to be made aware of, as well. So, what if I did an all female concert with several Atlantans that I have had the opportunity to share the stage with and truly admire? Each performer would be able to represent and bring awareness to a specific cause. VoilĂ ! DIVAS WITH A CAUSE was born!   

DIVA: a celebrated female singer, outstanding talent in the world of opera, closely related to that of "prima donna." Derived from the Italian noun "diva," which is a female deity. The basic sense of the term is "goddess," and thus distantly related to the Hindu term "deva." 

DIVAS WITH A CAUSE is a group of phenomenal vocalists with a shared vision. Our contribution of time and energy to the community has brought us together to motivate, educate and create more awareness about the causes that are dear to our hearts. We are dedicated to inspiring individuals to learn more about issues that can have detrimental effects on their lives. We want to give back, for as Luke 12:48 states, "For unto whomsoever much is given, of him shall be much required."

We are Dynamic Intellectual Vivacious Altruistic Singers with causes, who know that knowledge is power! We become more powerful when we share our knowledge about our various causes with others in the hope of giving them the power to conquer or make the necessary changes for a better quality of life.
   
Welcome to the DIVAS WITH A CAUSE website. We hope and pray that our actions and words will truly speak loudly and clearly to your hearts. We are setting out to make a difference in the lives of those individuals who are affected by these causes.
  
So, yes we are "DIVAS" ... not "just beCAUSE" but "with a CAUSE." Thank you for visiting DIVAS WITH A CAUSE. 

- Maryline Blackburn

Thursday, October 7, 2010

10 Things Every Woman Should Know About Lung Cancer

By Lynette Summerill
Originally Published on EmpowHER - Women's Health Online (http://www.empowher.com/).
10/07/2010.

Lynette Summerill is an award-winning writer who lives in Scottsdale, Arizona. In addition to writing about cancer-related issues, she writes a blog, Nonsmoking Nation, which follows global tobacco news and events.

1. Lung cancer affects women differently than men, and young women (under 40) are at greater risk for developing lung cancer than young men.

2. More women die of lung cancer than any other cancer, including breast cancer, ovarian cancer and uterine cancers combined. Smoking is the primary cause of lung cancer, so if you smoke, quit.

3. Your risk of lung cancer continues to decline with every year you don't smoke. However, if you used to smoke, you remain at increased risk for lung cancer for at least 20 years after you quit.

4. Radon is the second leading cause of lung cancer, so if you live in an area with high levels of radium in the bedrock, have your house tested for radon exposure. To find out more, go to http://jglcf.org/radon.aspx.

5. Risk factors for lung cancer other than smoking include lung scarring from infection with tuberculosis and occupational or environmental exposures to radon, second-hand smoke, radiation, asbestos, air pollution, arsenic and some organic chemicals.  [And genetic predisposition. - Joe Gaeta]

6. Symptoms of lung cancer may include a cough that won't go away, chest, shoulder or back pain that won't go away, unexplained wheezing, shortness of breath, hoarseness, coughing up blood, swelling in the neck and face, difficulty swallowing, weight loss and loss of appetite, increasing fatigue and weakness, and recurring respiratory infections such as pneumonia.

7. Lung cancer, like any other cancer, is most treatable when detected early. If you smoke now or smoked in the past, or have a family history of lung cancer, talk to your doctor about screening tests available to you.

8. Although lung cancer is a serious disease, women typically fare better than men after treatment for lung cancer.  [When treated early enough. - JG]

9. Eating a well balanced diet rich in fruits and vegetables helps reduce the risk of lung cancer.

10. Lung cancer research is significantly under-funded, despite the fact that lung cancer is the number one cancer killer of women in the U.S. Less money is spent on lung cancer research than on the next three top cancer killers. [To find out more information about lung cancer and how you can help, go to http://www.forjoan.org. - JG]

Tuesday, October 5, 2010

Women and Lung Cancer: A 21st Century Epidemic

By Lynette Summerill
Orginally Published on EmpowHER - Women's Health Online (http://www.empowher.com)



Medical researchers are faced with solving a difficult puzzle. Why is the prevalence of lung cancer in men decreasing at the same time it is increasing in women?

Lung cancer in U.S. women is a contemporary epidemic that only recently has started leveling off. Since the mid-1970s, the incidence of lung cancer in women has increase six-fold, becoming one of this country’s major health problems.

The human and financial burden of lung cancer is hard to comprehend. Currently, U.S. women have the highest lung cancer rates in the world. Last year alone, lung cancer killed enough U.S. women to equal or surpass the entire population of Muncie, Indiana, and killed more than breast, ovarian and uterine cancers combined. Every year, approximately $9.6 billion is spent in the U.S. treating this disease.This scene is repeated in other top economic countries, and is expected to take its toll on emerging economic nations in the next few decades.

But why is this happening? The short answer is nobody knows for sure and some of the “causes” are still controversial, but there are some pretty impressive clues that have been uncovered.

The incidence for women we are seeing now is a result of the rise in women's smoking from decades ago, says Michael Thun, a researcher and former head of the surveillance and epidemiology at the American Cancer Society. "Women as a group started smoking later than men and are slower to quit, and smoking is known to be the biggest contributor to lung cancer," he said.

Cigarette smoking in men and women is thought to cause up to 90 percent of all lung cancers in the U.S. This is a major concern as epidemiological data suggest that women may be more susceptible than men to develop lung cancer.

Smoking explains part of the trend, but it falls short in making clear why there has been an increase of lung cancer in never smokers, like Dana Reeve, the wife of Superman actor Christopher Reeve, who died of the disease in 2006, at the age of 44.

Research conducted by Neal Freedman of the National Cancer Institute and published in The Lancet Oncology July 2008 edition, found that women who have never smoked seem to be at higher risk of developing lung cancer than men who have never smoked. Other studies suggest one-in-five lung cancers are seen in never smokers. The majority of these cases are diagnosed in young women under age 40.

While still controversial, research has found some evidence that estrogen production may play a part in this puzzle. As in breast cancer, estrogen can serve as a tumor promoter, some studies suggest. Many lung cancer tumors have been found to have estrogen receptors on them in both men and women. The current hypothesis is since women produce more estrogen than men, they are more likely to have a reaction with the estrogen receptor in the tumors.

Beyond hormones, a laundry list of other factors may be putting women who have never smoked or former smokers at risk for lung cancer, including exposure to the human papilloma virus (HPV), hormone replacement therapy, as well as certain biomarkers that are more prevalent in women than men. Add environmental factors, such as exposure to secondhand smoke, asbestos, air pollution, high levels of arsenic in drinking water and radon gas in homes, and occupational exposure to dry cleaning chemicals and those used in nail salons and unraveling the lung cancer puzzle gets increasing complicated in the modern world.

While researchers don’t all agree on why women are increasingly being diagnosed with lung cancer, they do agree that lung cancer is woefully underfunded, in part because fewer lung cancer advocates exist when compared to other cancers. One reason is only about one in 10 patients live long enough to advocate on behalf of the disease.

Generally speaking, the news around lung cancer seems grim, but improvements in treatment have made leaps and more is known about this disease than just a few years ago, putting recovery in the grasp of more lung cancer patients.

Lynette Summerill is an award-winning writer who lives in Scottsdale, Arizona. In addition to writing about cancer-related issues, she writes a blog, Nonsmoking Nation, which follows global tobacco news and events.

Wednesday, June 9, 2010

Searching for the Source of Lung Cancer in Women

by Katherine Hobson

The Wall Street Journal

June 8, 2010


As doctors have substantially brought down the rate of lung cancer in men over the past three decades, they face a stubborn riddle: Why does it continue to grow among women?


A new study offers an intriguing possibility that the answer may involve estrogen.


Lung cancer is the leading cancer killer of both women and men. And overall, it still kills more men than women: Some 71,000 deaths are projected in women and 86,000 in men in 2010. That's a much higher casualty rate than the No. 2 killer, breast cancer, with about 40,000 deaths expected, according to the American Cancer Society.


Experts don't agree on whether women are naturally at greater risk for lung cancer or more vulnerable to the effects of tobacco smoke than men. Still, there are striking gender differences in cancer rates. For instance, women who have never smoked are far more likely than men who have never smoked to get lung cancer, according to data from the National Cancer Institute.


The diagnostic trajectory among women is concerning. Researchers are trying to understand why it is rising and what can be done to change it.


"Unless we start seeing a turnaround for women," says Brenda Edwards, associate director of the surveillance research program at the National Cancer Institute, "there will be as many women diagnosed with lung cancer in the next few years as men."


The rate of new cases of lung cancer has dropped for men to 72 in 100,000 males in 2007 from 89.5 in 100,000 in 1975. In women, however, the number of cases has more than doubled to 53 in 100,000 females in 2007 from 24.5 per 100,000 in 1975, according to the National Cancer Institute.


The hormone estrogen is a possible culprit. Certain forms of estrogen are known to help create genetic mutations in cells and contribute to tumor formation in the breast. Recently, researchers found out that lung cells in both women and men also make estrogen, raising the possibility that the hormone contributes to lung-cancer development.


Margie Clapper and her colleagues at Fox Chase Cancer Center, a major research center in Philadelphia, set out to examine what would happen to the lung cells of female animals that were exposed to tobacco smoke. They wanted to identify early genetic changes in the cells—before tumors formed—that could be targeted in the future.


"The goal is that one day these early genetic changes could be disrupted, preventing lung cancer from developing in the first place," says Dr. Clapper, co-leader of the cancer prevention and control program.


After placing female mice in smoke-filled chambers six hours a day, five days a week for three, eight or 20 weeks, they looked to see how material produced by genes differed in the lung tissue of animals that were exposed to smoke and those that weren't.


Researchers found differences in 10 genes around an enzyme called cytochrome P450 1b1, which is known to break down estrogen and tobacco smoke. The 1b1 enzyme activates cancer-causing agents in tobacco and converts estrogen to a more active form that appears to cause DNA mutations. Estrogen may, in essence, be adding fuel to the fire that occurs when lung cells are exposed to tobacco smoke.


The findings, published last week in the journal Cancer Prevention Research, "reinforce the role that estrogen is clearly a player and we need to look at it more closely," Dr. Clapper says.


Since only female mice were used in the study, it isn't clear how male mice—whose lung cells also produce estrogen—would react differently.


Dr. Clapper says that this estrogen pathway could be particularly harmful for women because they have higher levels of estrogen in their blood before menopause, and some may take drugs that boost estrogen, including hormone-replacement therapies or birth control pills.


The lab is now looking at what happens when hormone levels are boosted in mice that already have lung tumors, and also what hormones might do to damage cells even in a non-smoke environment.


The study "points to directions that we could take to either prevent or treat lung cancer," says Jill Siegfried, a pharmacology and chemical biology professor at the University of Pittsburgh who wrote a commentary, which accompanied Dr. Clapper's paper, on why the research is important. The research "also provides some public health information for women to understand what tobacco smoke is doing to their lungs and how it could interact with their natural hormones."


Some cancer researchers say that the rise in lung cancer cases in women is simply due to differences in men's and women's smoking patterns.


Women as a group started smoking later than men and are slower to quit, and smoking is known to be the biggest contributor to lung cancer, says Michael Thun, a researcher and former head of the surveillance and epidemiology group at the American Cancer Society. The rise in cases seen now for women is just a result of the rise in women's smoking from decades ago, he says.




Others say that while smoking patterns explain part of the trend, recent evidence suggests that women are more susceptible to lung cancer than men.  "One in five women diagnosed with lung cancer has never smoked compared with one in 12 men," says Tracey Hyams, director of the Connors Center for Women's Health and Gender Biology at the Harvard-affiliated Brigham and Women's Hospital in Boston.


Three times as many female never-smokers are diagnosed with lung cancer compared with male never-smokers, according to a report recently published by Dr. Hyams's group.

Monday, May 17, 2010

Deadlier to Women Than Breast, Ovarian and Cervical Combined

by Eleanor Clift
[The following was originally published at PoliticsDaily.com on May 17th, 2010.]


Women of every age know the threat that breast cancer poses. Girls grow up watching their mothers march against it, and that activism has brought much needed resources and attention to the disease. Yet the cancer that kills more women each year than breast, ovarian and cervical cancers combined is lung cancer. Because it was once mostly a male disease, and because it is associated with smoking, women assume if they never smoked, or if they stopped years ago, they don't need to be on the lookout for this deadly cancer.

But they do. Two-thirds of lung cancer's female victims quit at least a decade earlier or never smoked at all.

Yet the stigma of smoking and the shame people feel for bringing on their illness has caused smokers to delay seeking medical attention in the early stages of lung cancer. As a result, lung cancer rates have continued to rise, and 23 years ago, the disease overtook breast cancer as the leading cause of death in women. Yet who knew?

At a Capitol Hill briefing Wednesday, the Lung Cancer Alliance released a report about women and cancer titled, "Out of the Shadows," which documents the gaps in research funding and the need for equality in disease treatment. Lung cancer is now the cancer that women are most likely to die from. Among the report's findings: Women who have never smoked appear to be at two to three times greater risk for developing lung cancer than men who have never smoked. Women tend to develop lung cancer at younger ages than men, and the disease is striking more younger women who have never smoked. The report was prepared by Brigham and Women's Hospital's Women's Health Policy and Advocacy Program at the Connors Center for Women's Health and Gender Biology.

Among the speakers was Deborah Morosini, an M.D. and a pathologist and the sister of Dana Reeve, who died of lung cancer four years ago at age 44. Morosini recalled how her family giggled when Dana, an aspiring actress, started dating Superman, aka Christopher Reeve, after they met at summer theater at Williamstown. They went on to marry, and to live happily ever after, when a horseback riding accident turned Superman into a quadriplegic at age 41.

"It was one of the worst things that could happen," said Morosini, "but they didn't become victims." They took their tragedy out of the shadows and in the 11 years Reeve lived with his disability, the couple became an inspiration to others with spinal cord injuries. After her husband died at age 52, Dana returned to sing "Cabaret," putting her life and her career back on track. When she developed what Morosini says was a very mild cough, no one was particularly worried, not even when a lesion was found on her lung and her liver. Morosini figured it was a parasite that could be easily treated. "I'm a pathologist . . . . Why was this not on my radar?" she exclaimed before an audience of physicians, activists and survivors. Dana Reeve, who had never smoked, died seven months later. "This new report gives us an enormous platform from which to educate people about lung cancer," Morosini concluded.

Lung cancer has historically struck more men than women, but the gap is narrowing, and it will take more research dollars to understand the genetic and hormonal differences in how the disease affects women. Despite the incidence of lung cancer in non-smokers, smoking remains the most obvious risk factor. The report identifies "gendered health behaviors" such as the age of men and women when they start smoking, and even how they smoke, the number of puffs taken and how deeply they inhale. There are 45 million former smokers and 40 million current smokers in the U.S., and statistics tell us that half of them will die prematurely. If that's not enough of a wake-up call, check out Donna Trussell's report on the President's Cancer Panel, which says the "true burden of environmentally induced cancer has been grossly underestimated."

Developing a non-invasive early test is a research goal. Currently, 80 percent of lung cancers are found too late to respond to treatment. "Where are the dollars from the cigarette settlements?" asked one woman, who said she is in treatment for Stage 4 lung cancer. "I heard it's going for roads, not research." She heard right, explained one of the experts in the audience. The basis of the 1988 settlement with the four largest U.S. tobacco companies was to compensate states for expenses incurred treating people with tobacco-related illnesses. The states got the money with no strings attached, and funding research on a disease where patients are routinely blamed as responsible for their condition has not been a high priority.